Real-time enrollment status for this ocular myasthenia gravis clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 2:01 PM UTC
| NCT Number | NCT06558279 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Ocular Myasthenia Gravis |
| Phase | Clinical Trial |
| Target Enrollment | 124 participants |
| Active Locations | 11 sites in the US |
| Sponsor | argenx |
| Last Updated on CT.gov | December 15, 2025 (Dec 15, 2025) |
As of March 2, 2026: Clinical trial NCT06558279 is currently active_not_recruiting participants. This clinical trial study for ocular myasthenia gravis is not currently accepting new participants at 11 locations across the United States. The study is sponsored by argenx. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06558279 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06558279 was last updated Dec 15, 2025 (December 15, 2025). HelloStudys verifies this status automatically.